Clinical Trials Logo

Red Blood Cell Transfusion clinical trials

View clinical trials related to Red Blood Cell Transfusion.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05405426 Recruiting - Clinical trials for Extracorporeal Membrane Oxygenation

Trial of Indication-Based Transfusion of Red Blood Cells in ECMO

TITRE
Start date: April 14, 2023
Phase: N/A
Study type: Interventional

TITRE - Trial of Indication-based Transfusion of Red Blood Cells in ECMO, is a multicenter, prospective, randomized clinical trial. The overarching goal of TITRE is to determine whether restricting red blood cell (RBC) transfusion according to an indication-based strategy for those with bleeding and/or deficit of tissue oxygen delivery, compared with transfusion based on center-specific hemoglobin or hematocrit thresholds, can reduce organ dysfunction and improve later neurodevelopment in critically ill children receiving Extracorporeal Membrane Oxygenation (ECMO) support.

NCT ID: NCT04920045 Recruiting - Anemia Clinical Trials

A Trial to Assess the Effect of Transfusion Strategies on Fatigability Levels After Hospital Discharge

EToF
Start date: February 1, 2022
Phase: N/A
Study type: Interventional

This study is a randomized controlled trial in which hospitalized patients with anemia are randomized to receive transfusion at: a) Hb<9g/dL (liberal transfusion strategy), or b) Hb<7g/dL (restrictive transfusion strategy). We are measuring self-reported fatigability, fatigue, and activity levels at randomization and 7 days post hospital discharge in both trial arms. In a subset of 75 patients in each trial arm (150 total), we will are administering the 6 Minute Walk Test at randomization and 7 days post discharge.

NCT ID: NCT04757909 Recruiting - Anemia Clinical Trials

Detection of Anemizations in Primary Care.

ANHEMOG
Start date: March 30, 2017
Phase: N/A
Study type: Interventional

Objective: To evaluate the effect of the use of the hemoglobinometer in primary care on the clinical results of patients with chronic anemia. Methods: The ANHEMOG study is a randomized controlled trial with two parallel arms, intervention and control. It was approved at december 11, 2017. The study randomizes 138 patients with chronic anemia. In the intervention arm, a monthly capillary hemoglobin measurement will be performed with a hemoglobinometer. If a decrease in hemoglobin concentration is detected, an existing transfusion circuit will be followed. Social, demographic and quality of life variables will be collected from all participants. Hypothesis: The results of the research will have an impact on people with chronic anemia who would receive red blood cell transfusion when needed without delay. The improvement in the times of action would reduce decompensations from chronic diseases, visits to the emergency room and hospital admissions, and therefore would improve the quality of life of these patients. Furthermore, the management of the different interventions by the Case Management Nurse (EGC), in this regard, improves the current fragmentation of the different levels of care.